These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 23903003)

  • 1. Mosaic segmentation, COPD and CHF multimorbidity and hospital admission costs: a clinical linkage study.
    Doos L; Uttley J; Onyia I; Iqbal Z; Jones PW; Kadam UT
    J Public Health (Oxf); 2014 Jun; 36(2):317-24. PubMed ID: 23903003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic disease multimorbidity transitions across healthcare interfaces and associated costs: a clinical-linkage database study.
    Kadam UT; Uttley J; Jones PW; Iqbal Z
    BMJ Open; 2013; 3(7):. PubMed ID: 23872294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of comorbid conditions in COPD patients on health care resource utilization and costs in a predominantly Medicare population.
    Schwab P; Dhamane AD; Hopson SD; Moretz C; Annavarapu S; Burslem K; Renda A; Kaila S
    Int J Chron Obstruct Pulmon Dis; 2017; 12():735-744. PubMed ID: 28260880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multimorbidity combinations, costs of hospital care and potentially preventable emergency admissions in England: A cohort study.
    Stokes J; Guthrie B; Mercer SW; Rice N; Sutton M
    PLoS Med; 2021 Jan; 18(1):e1003514. PubMed ID: 33439870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population-based analysis of patients with COPD in Catalonia: a cohort study with implications for clinical management.
    Vela E; Tényi Á; Cano I; Monterde D; Cleries M; Garcia-Altes A; Hernandez C; Escarrabill J; Roca J
    BMJ Open; 2018 Mar; 8(3):e017283. PubMed ID: 29511004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using the BODE Index and Comorbidities to Predict Health Utilization Resources in Chronic Obstructive Pulmonary Disease.
    Li CL; Lin MH; Chen PS; Tsai YC; Shen LS; Kuo HC; Liu SF
    Int J Chron Obstruct Pulmon Dis; 2020; 15():389-395. PubMed ID: 32110007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of Patients With Congestive Heart Failure or Chronic Obstructive Pulmonary Disease Readmissions Within 30 Days Following an Acute Exacerbation.
    Castillo A; Edriss H; Selvan K; Nugent K
    Qual Manag Health Care; 2017; 26(3):152-159. PubMed ID: 28665906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three-Year Hospitalization and Mortality in Elderly Smokers with Chronic Obstructive Pulmonary Disease or Chronic Heart Failure.
    Beghé B; Fabbri LM; Garofalo M; Schito M; Verduri A; Bortolotti M; Stendardo M; Ruggieri V; Fucili A; Sverzellati N; Della Casa G; Maietti E; Clini EM; Boschetto P
    Respiration; 2019; 97(3):223-233. PubMed ID: 30205380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors contributing to hospitalization costs for patients with COPD in China: a retrospective analysis of medical record data.
    Li M; Wang F; Chen R; Liang Z; Zhou Y; Yang Y; Chen S; Ung COL; Hu H
    Int J Chron Obstruct Pulmon Dis; 2018; 13():3349-3357. PubMed ID: 30349238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comorbidities as a driver of the excess costs of community-acquired pneumonia in U.S. commercially-insured working age adults.
    Polsky D; Bonafede M; Suaya JA
    BMC Health Serv Res; 2012 Oct; 12():379. PubMed ID: 23113880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health care and social care costs of pneumonia in Denmark: a register-based study of all citizens and patients with COPD in three municipalities.
    Brogaard SL; Nielsen MB; Nielsen LU; Albretsen TM; Bundgaard M; Anker N; Appel M; Gustavsen K; Lindkvist RM; Skjoldan A; Breinhild G; Poulsen PB
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2303-9. PubMed ID: 26604729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of population and primary healthcare factors with hospital admission rates for chronic obstructive pulmonary disease in England: national cross-sectional study.
    Calderón-Larrañaga A; Carney L; Soljak M; Bottle A; Partridge M; Bell D; Abi-Aad G; Aylin P; Majeed A
    Thorax; 2011 Mar; 66(3):191-6. PubMed ID: 21076143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Healthcare costs with tiotropium plus usual care versus usual care alone following 1 year of treatment in patients with chronic obstructive pulmonary disorder (COPD).
    Friedman M; Menjoge SS; Anton SF; Kesten S
    Pharmacoeconomics; 2004; 22(11):741-9. PubMed ID: 15250751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Health Diary Telemonitoring and Hospital-Based Home Care Improve Quality of Life Among Elderly Multimorbid COPD and Chronic Heart Failure Subjects.
    Persson HL; Lyth J; Lind L
    Int J Chron Obstruct Pulmon Dis; 2020; 15():527-541. PubMed ID: 32210547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consumer segmentation and time interval between types of hospital admission: a clinical linkage database study.
    Kadam UT; Lawson CA; Moody DK; Teece L; Uttley J; Harvey J; Iqbal Z; Jones PW
    J Public Health (Oxf); 2018 Mar; 40(1):154-162. PubMed ID: 28334927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Torasemide: a pharmacoeconomic review of its use in chronic heart failure.
    Young M; Plosker GL
    Pharmacoeconomics; 2001; 19(6):679-703. PubMed ID: 11456215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One-year stability of care dependency in patients with advanced chronic organ failure.
    Janssen DJ; Schols JM; Wouters EF; Spruit MA
    J Am Med Dir Assoc; 2014 Feb; 15(2):127-32. PubMed ID: 24314701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heart failure and chronic obstructive pulmonary disease multimorbidity at hospital discharge transition: a study of patient and carer experience.
    Doos L; Bradley E; Rushton CA; Satchithananda D; Davies SJ; Kadam UT
    Health Expect; 2015 Dec; 18(6):2401-12. PubMed ID: 24831061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multimorbidity in Asthma, Allergic Conditions and COPD Increase Disease Severity, Drug Use and Costs: The Finnish Pharmacy Survey.
    Jantunen J; Haahtela T; Salimäki J; Linna M; Mäkelä M; Pelkonen A; Kauppi P
    Int Arch Allergy Immunol; 2019; 179(4):273-280. PubMed ID: 30999310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct Hospitalization Cost of Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease in Vietnam.
    Ngo CQ; Thi Bui T; Vu GV; Chu HT; Phan PT; Ngoc Pham H; Vu GT; Nguyen LH; Ha GH; Tran BX; Latkin CA; Ho CSH; Ho RCM
    Int J Environ Res Public Health; 2018 Dec; 16(1):. PubMed ID: 30598020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.